FDA Inspection
Optimus Pharma Private LimitedOptimus Pharma Private Limited – FDA Inspection, Jun 23, 2023
Record Details
This FDA Inspection record concerns Optimus Pharma Private Limited, with an inspection on June 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 66f0a7c9-2544-4107-a868-3815644a5f7e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208725
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.67(b)(5)Cleaning SOPs/equipment protection
- 21 CFR 211.84(c)(4)Composite sample top/middle/bottom
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Optimus Pharma Private Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2025 | Not classified | Office of Inspections and Investigations | |
| September 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Optimus Pharma Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.